The Latest Cardiac and Vascular News
SUNNYVALE, Calif.–(BUSINESS WIRE)– Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, today announced that medical device industry veteran Donald J. Zurbay has joined its board of directors. Zurbay brings 28 years of executive leadership and financial experience primarily from the healthcare sector. […]
WASHINGTON, March 23, 2018 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the United States Patent and Trademark Office (USPTO) decided in Edwards’ favor in an Inter Partes Review (IPR) of Boston Scientific’s U.S. transcatheter heart valve patent, […]
MINNEAPOLIS–(BUSINESS WIRE)– Smiths Medical, Inc. today announced the U.S. commercial launch of Delta Med SpA’s DeltaVen® Closed System Catheter and the Food and Drug Administration (FDA) clearance. DeltaVen® is the next advancement in Peripheral IV Catheters (PIVC); offering the needle, extension tubing, and an option for a needleless connecter in an “all in one” […]
DUBLIN–(BUSINESS WIRE)–The “North America Electrocardiograph (ECG) Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. The North America Electrocardiograph (ECG) Market is expected to witness market growth of 4.9% CAGR during the forecast period (2017 – 2023). Electrocardiography (ECG) is a non-invasive medical test used in recording electrical activity of the heartbeat over […]
DUBLIN–(BUSINESS WIRE)–The “North America Vascular Graft Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. The North America Vascular Graft Market is expected to witness market growth of 5.4% CAGR during the forecast period (2017 – 2023). A vascular graft is a medical device which is used as an artificial blood vessel. These […]
IRVINE, Calif.–(BUSINESS WIRE)–JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced the appointment of veteran medical device executive Keith D. Dawkins, M.D., as a new JenaValve board member. “As JenaValve advances its clinical development […]
DUBLIN–(BUSINESS WIRE)–The “Global Transcatheter Aortic Valve Implantation (TAVI) Market: Industry Analysis & Outlook (2018-2022)” report has been added to ResearchAndMarkets.com’s offering. “Global TAVI Market: Industry Analysis & Outlook (2018-2022)” analyses the development of this market, with focus on the U.S and European markets. The global TAVI market is expected to grow in future due […]
VANCOUVER, March 23, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company“) (NASDAQ, TSX:NVCN) announced today that it has received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum market value requirement set forth in Nasdaq Rules […]
IRVINE, Calif.–(BUSINESS WIRE)– JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced the appointment of veteran medical device executive Keith D. Dawkins, M.D., as a new JenaValve board member. “As JenaValve advances its clinical development […]
AMSTERDAM, March 23, 2018 /CNW/ – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology has delivered a broad range of health technology solutions to the University of Ottawa Heart Institute (UOHI) – Canada’s largest and foremost heart health centre dedicated to understanding, treating, and preventing heart disease. Today, […]
